Cognitive impairment in patients with chronic hepatitis treated with interferon alpha (IFNα): results from a prospective study
Authors:
- Marc A. EngelbrechtMEMarc A. Engelbrecht
- Oliver GutOGOliver Gut
- Bernd L. FiebichBFBernd L. Fiebich
- Joachim BauerJBJoachim Bauer
- Gesa JanssenGJGesa Janssen
- Martin SchaeferMSMartin Schaefer
- 16 April 2006
- journal article
- clinical trial
- Published by Cambridge University Press (CUP) in European Psychiatry
- Vol. 21 (3) , 204-210
Abstract
Background.: Treatment with low-dose interferon alpha (IFN-α) is often associated with neuropsychiatric side effects. In addition to depression and anxiety, IFN-α associated cognitive impairment significantly affects patient’s mental health and quality of life.Aims of the study.: To measure possible effects of low-dose IFN-α on cognitive functioning and its relationship to the development of depression and anxiety.Method.: We prospectively followed 38 patients with a chronic hepatitis B or C by neuropsychological tests and psychiatric self-rating scales during 12 weeks of low-dose treatment with IFN-α.Results.: Before IFN-α treatment, neuropsychological tests as well as self-ratings in the Beck’s Depression Inventory (BDI), the Hospital Anxiety and Depression Scale (HADS) and the Self-Report Symptom Inventory 90 Items-Revised (SCL-90-R) were within the normal range. Following 12 weeks of treatment with IFN-α resulted in a slight, but significant increase in depression scores. Neuropsychological assessment after 12 weeks of IFN-α treatment showed a significant decrease of the immediate recall in the Auditory-Verbal Learning Test (AVLT) and a significant reduction of words recited in the Controlled Oral Word Association Test (COWA). Cognitive impairment did not significantly correlate with depressive symptoms or anxiety.Conclusion.: Our results indicate that even low-dose IFN-α induces cognitive impairment independent from depressive symptoms, which might be related to functional disturbances in the prefrontal cortex and the hippocampus. We suggest close monitoring of cognitive function during IFN-α treatment of chronic hepatitis.Keywords
This publication has 42 references indexed in Scilit:
- Psychotic Depression Occurring After Stopping Interferon-[small alpha, Greek]Journal of Clinical Psychopharmacology, 1999
- Differential Effects of Early Hippocampal Pathology on Episodic and Semantic MemoryScience, 1997
- Side effects of high-dose interferon therapy for chronic hepatitis CJournal of Hepatology, 1996
- A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferonJournal of Hepatology, 1996
- Interleukin-1 and Tumor Necrosis Factor-α Synergistically Mediate Neurotoxicity: Involvement of Nitric Oxide and of N-Methyl-D-aspartate ReceptorsBrain, Behavior, and Immunity, 1995
- Interferon-α-2aDrugs, 1995
- Suicide associated with alfa-interferon therapy for chronic viral hepatitisJournal of Hepatology, 1994
- Neuropsychological AssessmentAnnual Review of Psychology, 1994
- Side Effects of Alpha InterferonSeminars in Liver Disease, 1989
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983